BioCentury
ARTICLE | Clinical News

Marduox maxacalcitol/betamethasone butyrate propionate regulatory update

April 11, 2016 7:00 AM UTC

Japan approved an NDA from Chugai for Marduox maxacalcitol/betamethasone butyrate propionate to treat psoriasis vulgaris. The product is a topical combination of Oxarol maxacalcitol, an active vitamin...